Usability, Perceived Usefulness, and Shared Decision-Making Features of the AFib 2gether Mobile App: Protocol for a Single-Arm Intervention Study

Kapoor, Alok; Andrade, Andreza; Hayes, Anna; Mazor, Kathleen M.; Possidente, Carl J.; Nolen, Kim; Hegeman-Dingle, Rozelle; McManus, David D.

doi:10.2196/21986

Cited by 7 publications

(10 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, educational content is available. The protocol of a single-arm intervention study to assess usability and perceived usefulness has been published [ 23 ]. The usability categories of functionality and aesthetics were rated as 4.51 and 4.26 out of 5 by 37 patients and 4.19 and 4.04 out of 5 by 13 physicians, respectively, using the Mobile App Rating Scale [ 24 ].…”

Section: Resultsmentioning

confidence: 99%

Smartphone Apps for Managing Antithrombotic Therapy: Scoping Literature Review

Praus¹,

Krzowski²,

Walther³

et al. 2022

JMIR Cardio

View full text Add to dashboard Cite

Background Antithrombotic therapy is complex and requires informed decisions and high therapy adherence. Several mobile phone apps exist to either support physicians in the management of antithrombotic therapies or to educate and support patients. For the majority of these apps, both their medical evidence and their development background are unknown. Objective This review aims to investigate the available literature describing high-quality apps for managing antithrombotic therapy based on professional scientific information. Methods Keywords and Medical Subject Heading terms were used to search MEDLINE via PubMed and Ovid between December 2019 and January 2022. Inclusion criteria were the availability of full text and publications in the English language. Apps that solely focused on atrial fibrillation were excluded. Qualitative findings were thematically synthesized and reported narratively. Results Out of 149 identified records, 32 were classified as eligible. We identified four groups: (1) apps for patients supporting self-management of vitamin K antagonists, (2) apps for patients increasing therapy adherence, (3) educational apps for patients, and (4) apps for physicians in supporting guideline adherence. Conclusions Throughout the evaluated data, patients from all age groups receiving antithrombotic drugs expressed the desire for a digital tool that could support their therapy management. In addition, physicians using mobile guideline-based apps may have contributed to decreased adverse event rates among their patients. In general, digital apps encompassing both user-friendly designs and scientific backgrounds may enhance the safety of antithrombotic therapies. However, our evaluation did not identify any apps that addressed all antithrombotic drugs in combination with perioperative stratification strategies. Currently, strict regulations for smartphone apps seem to negatively affect the development of new apps. Therefore, new legal policies for medical digital apps are urgently needed.

show abstract

Section: Resultsmentioning

confidence: 99%

Smartphone Apps for Managing Antithrombotic Therapy: Scoping Literature Review

Praus¹,

Krzowski²,

Walther³

et al. 2022

JMIR Cardio

View full text Add to dashboard Cite

show abstract

“…We previously published a protocol for integrating the AFib 2gether app in encounters between patients and their cardiology providers [ 13 ]. We briefly summarize the methods below.…”

Section: Methodsmentioning

confidence: 99%

“…The app has not been previously tested with patients and providers for usability, perceived usefulness, frequency of AC starts occurring after visits in which providers and patients use the app, or evidence of shared decision-making. We recently published a protocol to evaluate the usability, perceived usefulness, and feasibility of the app for actual clinical encounters between patients with AF and their cardiology providers [ 13 ]. This paper reports the results from the completed study and their interpretation.…”

Section: Introductionmentioning

confidence: 99%

Usability and Perceived Usefulness of the AFib 2gether Mobile App in a Clinical Setting: Single-Arm Intervention Study

Kapoor¹,

Hayes²,

Patel³

et al. 2021

JMIR Cardio

Self Cite

View full text Add to dashboard Cite

Background Although the American Heart Association and other professional societies have recommended shared decision-making as a way for patients with atrial fibrillation (AF) or atrial flutter to make informed decisions about using anticoagulation (AC), the best method for facilitating shared decision-making remains uncertain. Objective The aim of this study is to assess the AFib 2gether mobile app for usability, perceived usefulness, and the extent and nature of shared decision-making that occurred for clinical encounters between patients with AF and their cardiology providers in which the app was used. Methods We identified patients visiting a cardiology provider between October 2019 and May 2020. We measured usability from patients and providers using the Mobile App Rating Scale. From the 8 items of the Mobile App Rating Scale, we reported the average score (out of 5) for domains of functionality, esthetics, and overall quality. We administered a 3-item questionnaire to patients relating to their perceived usefulness of the app and a separate 3-item questionnaire to providers to measure their perceived usefulness of the app. We performed a chart review to track the occurrence of AC within 6 months of the index visit. We also audio recorded a subset of the encounters to identify evidence of shared decision-making. Results We facilitated shared decision-making visits for 37 patients visiting 13 providers. In terms of usability, patients’ average ratings of functionality, esthetics, and overall quality were 4.51 (SD 0.61), 4.26 (SD 0.51), and 4.24 (SD 0.89), respectively. In terms of usefulness, 41% (15/37) of patients agreed that the app improved their knowledge regarding AC, and 62% (23/37) agreed that the app helped clarify to their provider their preferences regarding AC. Among providers, 79% (27/34) agreed that the app helped clarify their patients’ preferences, 82% (28/34) agreed that the app saved them time, and 59% (20/34) agreed that the app helped their patients make decisions about AC. In addition, 32% (12/37) of patients started AC after their shared decision-making visits. We audio recorded 25 encounters. Of these, 84% (21/25) included the mention of AC for AF, 44% (11/25) included the discussion of multiple options for AC, 72% (18/25) included a provider recommendation for AC, and 48% (12/25) included the evidence of patient involvement in the discussion. Conclusions Patients and providers rated the app with high usability and perceived usefulness. Moreover, one-third of the patients began AC, and approximately 50% (12/25) of the encounters showed evidence of patient involvement in decision-making. In the future, we plan to study the effect of the app on a larger sample and with a controlled study design. Trial Registration ClinicalTrials.gov NCT04118270; https://clinicaltrials.gov/ct2/show/NCT04118270 International Registered Report Identifier (IRRID) RR2-21986

show abstract

“…The first tool is the free mobile app AFib2gether developed by Pfizer Inc., which improves shared decision-making between patients with AF on AC and cardiology providers. 22 The second tool is part of a CardioSmart initiative, which is a patient engagement program designed to support patient and clinician partnership and includes "A Decision Aid for Afib Stroke Prevention for Patients with Atrial Fibrillation." 23 Lastly, we will add a comment feature that allows providers to leave suggestions on how the alert, associated smart set, appearance of alert, overall user experience, and linkages can be optimized for the best experience for providers.…”

Section: Alert Enhancementsmentioning

confidence: 99%

Section: Alert Enhancementsmentioning

confidence: 99%

SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocol

Patel

Sadiq

Catanzaro

et al. 2021

Cardiovascular Digital Health Journal

Self Cite

View full text Add to dashboard Cite

BACKGROUND Six million Americans suffer from atrial fibrillation (AF), a heart rhythm abnormality that significantly increases the risk of stroke. AF is responsible for 15% of ischemic strokes, which lead to permanent disability in 60% of cases and death in up to 20%. Anticoagulation (AC) is the mainstay for stroke prevention in patients with AF. Despite guidelines recommending AC for patients, up to half of eligible patients are not on AC. Clinical decision support tools in the electronic health record (EHR) can help bridge the disparity in AC prescription for patients with AF.OBJECTIVE To enhance and assess the effectiveness of our previous rule-based alert on AC initiation and persistence in a diverse patient population from UMass-Memorial Medical Center and University of Florida at Jacksonville. METHODS Using the EHR Q5, we will track AC initiation and persistence. We will interview both patients and providers to determine a measure of satisfaction with AC management. We will track digital crumbs to better understand the alert's mechanism of effect and further add enhancements. These enhancements will be used to refine the alert and aid in developing an implementation toolkit to facilitate use of the alert at other health systems.CONCLUSION If the number of AC starts, the likelihood of persisting on AC, and the frequency alert use are found to be higher among intervention vs control providers, we believe such findings will confirm our hypothesis on the effectiveness of our alert.

show abstract

Usability, Perceived Usefulness, and Shared Decision-Making Features of the AFib 2gether Mobile App: Protocol for a Single-Arm Intervention Study

Cited by 7 publications

References 17 publications

Smartphone Apps for Managing Antithrombotic Therapy: Scoping Literature Review

Smartphone Apps for Managing Antithrombotic Therapy: Scoping Literature Review

Usability and Perceived Usefulness of the AFib 2gether Mobile App in a Clinical Setting: Single-Arm Intervention Study

SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocol

Contact Info

Product

Resources

About